Literature DB >> 22182601

Preparation and characterization of 5-fluorouracil pH-sensitive niosome and its tumor-targeted evaluation: in vitro and in vivo.

Mi Wang1, Yue Yuan, Yang Gao, Hong-Mei Ma, Hong-Tao Xu, Xiao-Ning Zhang, Wei-San Pan.   

Abstract

The purpose of this study was to investigate preparation, characterization and tumor-targeted effect of pH-sensitive niosomes, composed of a nonionic surfactant mixed with cholesteryl hemisuccinate (CHEMS), a derivative of cholesterol (CHOL), as a pH-sensitive molecule. CHEMS was synthesized with CHOL and succinic acid, the structure of which was analyzed by Mass spectrometry (MS) and ¹H Nuclear magnetic resonance (¹H NMR) spectrum. Niosomes were prepared via film hydration-probe ultrasound method. Both normal niosomes and pH-sensitive niosomes showed spherical morphology under transmission electron microscope (TEM) with a average particle sizes of 172 ± 6.2 nm and 153 ± 4.7 nm, respectively. The thermotropic behavior, structure changes and interaction of 5-fluorouracil (5-Fu) with other materials were characterized by differential scanning calorimetry (DSC), and the disappearance of the melting peak of drug revealed the fact that drug was encapsulated in niosomes. Bulk-equilibrium reverse-dialysis method was chosen to investigate the behavior of drug release from normal niosomes and pH-sensitive niosomes in different pH medium, and the results showed that the noisome containing CHEMS had a pH-sensitive property. Tumor-targeted effect was proved by the fact that pH-sensitive niosomes showed a remarkable high concentration in tumor site of the mice transplanted with tumor cell.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22182601     DOI: 10.3109/03639045.2011.641565

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  6 in total

1.  Formulation and pharmacokinetics of thermosensitive stealth® liposomes encapsulating 5-Fluorouracil.

Authors:  Chantal Al Sabbagh; Nicolas Tsapis; Anthony Novell; Patricia Calleja-Gonzalez; Jean-Michel Escoffre; Ayache Bouakaz; Hélène Chacun; Stéphanie Denis; Juliette Vergnaud; Claire Gueutin; Elias Fattal
Journal:  Pharm Res       Date:  2014-11-22       Impact factor: 4.200

2.  Development and characterization of mixed niosomes for oral delivery using candesartan cilexetil as a model poorly water-soluble drug.

Authors:  Zerrin Sezgin-Bayindir; Mustafa Naim Antep; Nilufer Yuksel
Journal:  AAPS PharmSciTech       Date:  2014-09-10       Impact factor: 3.246

Review 3.  Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence.

Authors:  Samar Zuhair Alshawwa; Abeer Ahmed Kassem; Ragwa Mohamed Farid; Shaimaa Khamis Mostafa; Gihan Salah Labib
Journal:  Pharmaceutics       Date:  2022-04-18       Impact factor: 6.525

Review 4.  Current Advances in Specialised Niosomal Drug Delivery: Manufacture, Characterization and Drug Delivery Applications.

Authors:  Bwalya A Witika; Kokoette E Bassey; Patrick H Demana; Xavier Siwe-Noundou; Madan S Poka
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

5.  Development of a novel niosomal system for oral delivery of Ginkgo biloba extract.

Authors:  Ye Jin; Jingyuan Wen; Sanjay Garg; Da Liu; Yulin Zhou; Lirong Teng; Weiyu Zhang
Journal:  Int J Nanomedicine       Date:  2013-01-24

6.  Ammonium glycyrrhizinate-loaded niosomes as a potential nanotherapeutic system for anti-inflammatory activity in murine models.

Authors:  Carlotta Marianecci; Federica Rinaldi; Luisa Di Marzio; Marica Mastriota; Stefano Pieretti; Christian Celia; Donatella Paolino; Michelangelo Iannone; Massimo Fresta; Maria Carafa
Journal:  Int J Nanomedicine       Date:  2014-01-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.